High-density lipoproteins inhibit inflammatory pathways in human monocytes activated upon chronic inflammatory conditions by cellular contact with stimulated T cells

Cytokine ◽  
2009 ◽  
Vol 48 (1-2) ◽  
pp. 51
Author(s):  
Danielle Burger ◽  
Lyssia Gruaz ◽  
Jean-Michel Dayer
2017 ◽  
Vol 58 (8) ◽  
pp. 1514-1523 ◽  
Author(s):  
Cesar M. Rueda ◽  
Ana Lucia Rodríguez-Perea ◽  
Maria Moreno-Fernandez ◽  
Courtney M. Jackson ◽  
John T. Melchior ◽  
...  

PLoS ONE ◽  
2010 ◽  
Vol 5 (2) ◽  
pp. e9418 ◽  
Author(s):  
Lyssia Gruaz ◽  
Céline Delucinge-Vivier ◽  
Patrick Descombes ◽  
Jean-Michel Dayer ◽  
Danielle Burger

2016 ◽  
Author(s):  
Lidia Ibanez ◽  
Grazia Abou-Ezzi ◽  
Thomas Ciucci ◽  
Vanessa Amiot ◽  
Anna Mansour ◽  
...  

Medicines ◽  
2021 ◽  
Vol 8 (7) ◽  
pp. 38
Author(s):  
Kyung-Hyun Cho

The composition and properties of apolipoprotein (apo) A-I and apoA-II in high-density lipoproteins (HDL) might be critical to SARS-CoV-2 infection via SR-BI and antiviral activity against COVID-19. HDL containing native apoA-I showed potent antiviral activity, while HDL containing glycated apoA-I or other apolipoproteins did not. However, there has been no report to elucidate the putative role of apoA-II in the antiviral activity of HDL.


Sign in / Sign up

Export Citation Format

Share Document